In a healthy human eye, the retina is physically attached to the choroid via the retinal pigment epithelium (“RPE”) in a generally circumferential, e.g., hemi-spherical, manner behind the pars plana. The vitreous humor, a transparent jelly-like material that fills the posterior segment of the eye, helps to cause the remainder of the retina to lie against, but not physically attach to, the choroid.
Sometimes a portion of the retina may break or tear and detach from the RPE. In certain examples, retinal detachment allows liquid vitreous humor and sometimes, aqueous humor, to flow between the retina and the RPE, creating a build-up of subretinal fluid. Either condition may result in a loss of vision for the patient.
During surgical repair or reattachment of the retina, a surgeon may insert a vitreoretinal instrument into the posterior segment of the eye via a sclerotomy, which is an incision through the sclera at the pars plana. The surgeon may also insert an endoilluminator and an infusion cannula into the eye via similar incisions, and may sometimes substitute an aspiration probe for the vitreoretinal instrument. While viewing the posterior segment under a microscope and with the aid of the endoilluminator, the surgeon may cut and aspirate away vitreous humor using the vitreoretinal instrument to gain access to the retinal detachment or tear. During this portion of the procedure, a saline solution may be infused into the eye via the infusion cannula to maintain the appropriate intraocular pressure.
Next, the surgeon may remove fluid from under the retina and inject air, an air-gas mixture, or a perfluorocarbon to re-approximate the detached portion of the retina in the proper location and flatten the retina against the RPE or choroid. A soft tip cannula, forceps, or other tool may be utilized for such manipulation. In certain cases, a perfluorocarbon liquid is injected into the posterior segment of the eye as a retinal tamponade while saline solution is displaced and removed therefrom, a procedure which may be referred to as “fluid/perfluorocarbon exchange.” In certain cases, air is injected as a retinal tamponade fluid while the saline solution is aspirated, a procedure which may be referred to as “fluid/air exchange.” In certain other cases, a mixture of air and gas, such as SF6, C3F8, or C2F6, is injected as a retinal tamponade fluid while the saline solution is aspirated, a procedure which may be referred to as “fluid/gas exchange.” As used herein, a “fluid” may include any liquid or gas that is suitable for use in the eye, including, but not limited to, saline solution with or without additives, silicone oil, a perfluorocarbon liquid, air, or a perfluorocarbon gas.
After performing one of the above-described exchanges, the surgeon may drain, e.g., aspirate via a suitable cannula, metal cannula, or soft tip cannula, any subretinal fluid present between the retina and the choroid through the retinal break or a drainage retinotomy, and thereafter use a laser probe to repair or reattach the retina via endophotocoagulation. To effect the repair, the retina must be placed against the RPE or choroid so that the RPE will absorb laser energy from the laser probe. The presence of subretinal fluid between the retina and the choroid may prevent laser uptake during repair of the retina, leading to inefficiencies during such procedures. Accordingly, it is advantageous to drain subretinal fluid from the surgical site, via an aspiration probe, before endophotocoagulation with a laser probe.
In certain cases, after the initial drainage of subretinal fluid, subretinal fluid may re-accumulate at the surgical site due to posterior flow, thereby requiring additional drainage. When using a conventional aspiration probe and laser probe, the aspiration probe must be either maintained within the posterior segment of the eye during endophotocoagulation, which would require a chandelier for illumination, or be re-inserted through the same or a new incision as the laser probe. However, repeated removal and insertion to exchange the aspiration probe and laser probe may cause unnecessary trauma to the eye at the incision site, retina or lens bump during tool exchange, and/or procedural delay during the retinal repair.
According to certain embodiments, an instrument for removing subretinal fluid from an eye is provided. The instrument comprises: a handle; a cannula coupled to the handle, a distal portion of the cannula having a curvature corresponding to a curvature of a retina of the eye, the cannula further comprising: a lumen extending through the cannula; and at least one port adjacent to a distal end of the cannula for aspirating subretinal fluid from the eye into the lumen; a first optical fiber extending through the cannula for propagating an illumination light through the distal end of the cannula; and a second optical fiber extending through the cannula for propagating a laser light through the distal end of the cannula.
So that the manner in which the above-recited features of the present disclosure can be understood in detail, a more particular description of the disclosure, briefly summarized above, may be had by reference to embodiments, some of which are illustrated in the appended drawings. It is to be noted, however, that the appended drawings illustrate only exemplary embodiments and are therefore not to be considered limiting of its scope, and may admit to other equally effective embodiments.
To facilitate understanding, identical reference numerals have been used, where possible, to designate identical elements that are common to the Figures. It is contemplated that elements and features of one embodiment may be beneficially incorporated in other embodiments without further recitation.
In the following description, details are set forth by way of example to facilitate an understanding of the disclosed subject matter. It should be apparent to a person of ordinary skill in the field, however, that the disclosed implementations are exemplary and not exhaustive of all possible implementations. Thus, it should be understood that reference to the described examples is not intended to limit the scope of the disclosure. Any alterations and further modifications to the described devices, instruments, methods, and any further application of the principles of the present disclosure are fully contemplated as would normally occur to one skilled in the art to which the disclosure relates. In particular, it is fully contemplated that the features, components, and/or steps described with respect to one implementation may be combined with the features, components, and/or steps described with respect to other implementations of the present disclosure.
Note that, as described herein, a distal end, segment, or portion of a component refers to the end, segment, or portion that is closer to a patient's body during use thereof. On the other hand, a proximal end, segment, or portion of the component refers to the end, segment, or portion that is distanced further away from the patient's body.
As used herein, the term “about” may refer to a +/−10% variation from the nominal value. It is to be understood that such a variation can be included in any value provided herein.
The present disclosure relates generally to small-gauge instrumentation (e.g., 23, 25, or 27 gauge) for surgical procedures, and more specifically, to vitreoretinal instruments for retinal repair and reattachment procedures, as well as associated methods of use. Certain embodiments of the present disclosure provide a curved or articulating probe configured to provide illumination, fluid aspiration, and endophotocoagulation. Accordingly, the probe enables aspiration of subretinal fluid that re-accumulates after initial drainage and during endophotocoagulation without the need to exchange surgical instruments or insert an additional instrument into the intraocular space. Furthermore, the combined functionalities of the probe enable a surgeon to simultaneously perform scleral depression with the surgeon's other hand while aspirating fluid and/or performing retinal endophotocoagulation. As a result, utilization of the aforementioned probe enables improved procedural efficiency and reduced risk of injury to the patient's eye.
Referring again to
Handle 120 further includes a plurality of ports 128 (e.g., three ports 128a-c are depicted in
Note that in the example of
Cannula 110 extends axially from distal end 124 of handle 120 and may be directly or indirectly coupled to handle 120 within an interior chamber thereof. Generally, cannula 110 is formed of a flexible or elastic material such as, e.g., a superelastic or shape memory alloy, which may still have enough rigidity to facilitate manipulation of ocular tissues during a surgical procedure. Examples of suitable superelastic alloys include nickel titanium (i.e., nitinol (Nickel Titanium Naval Ordinance Laboratory)) and spring steel. However, other flexible metals are also contemplated. In certain embodiments, cannula 110 includes a proximal, straight portion 114 and a distal, curved portion 116. With reference to
Cannula 110 may generally have an outer diameter D less than about 20 gauge, such as an outer diameter D of less than about 23 gauge, 25, gauge, 27 gauge, or 29 gauge. In certain embodiments, as shown in
Curved portion 116 of cannula 110 is disposed distally relative to straight portion 114 and is defined by outer curved surface 304 and inner curved surface 306. In certain embodiments, curved portion 116, or at least inner curved surface 306, has a radius of curvature similar to that of the retina of a patient's eye, e.g., retina 210 in
Curved portion 116 further includes one or more aspiration ports 302 disposed along an outer curved surface 304 thereof that may be fluidly coupled to, e.g., vacuum source 132 via an interior lumen 330. Lumen 330 serves as an aspiration channel through cannula 110 to an interior chamber of handle 120, as well as to tube 130a shown in
As described above, surgical instrument 100 is configured to propagate and deliver both illumination light and laser light to eye 200 via one or more optical fibers disposed within cannula 110.
First optical fiber 310 may be designed to operate as an optical waveguide and propagate illumination light 312 produced by illumination light source 134 (e.g., a light engine) through distal end 112 of cannula 110 to illuminate a surgical site within an intraocular space, e.g., a site or retinal tear or detachment. In certain embodiments, first optical fiber 310 is an optical nanofiber having a diameter less than about 30 μm (micrometers), such as a diameter between about 20 μm and about 30 μm. In such embodiments, the reduced overall cross-sectional footprint (i.e., area occupied) of first optical fiber 310 increases the amount of unoccupied cross-sectional area within lumen 330, thereby providing a wider fluid flowpath and improving flow of aspirated ocular materials through lumen 330. Further, an optical nanofiber may have a reduced stiffness as compared to larger, more conventional optical fiber, thus enabling relatively greater flexibility (e.g., bending over a greater range of angles) of cannula 110.
As depicted in
In certain embodiments, illumination light source 134 may be used to provide illumination light 312 to first optical fiber 310 in a continuous or pulsed manner, which may then be propagated by first optical fiber 310 through distal end 112 of cannula 110 in one of a variety of ways. Illumination light source 134 may be any suitable type of light source, such as a light emitting diode (LED)-based light source or a superluminescent diode (SLED)-based light source. However, other types of light sources are further contemplated, such as xenon- or halogen-based light sources, UV (Ultraviolet) light sources, white light sources, etc. As described above, illumination light source 134 may be part of an illumination module within a surgical console, or may be a separate, standalone light engine.
Similar to first optical fiber 310, second optical fiber 320 may be designed to operate as an optical waveguide and propagate laser light 322 produced by laser light source 136 (e.g., a laser engine) through distal end 112 of cannula 110 to repair retinal tissue (labeled 210 in
The characteristics of laser light 322 propagated through second optical fiber 320 are such that laser light 322 coagulates retinal tissue within the path of laser light 322 via thermal energy, which then heals to seal the retina 210. Burning is effected by laser light 322 heating the tissue to a temperature above 50° C. (degrees Celsius) but below 100° C., at which point proteins in the tissue denature and thrombocytes initiate coagulation. Accordingly, laser light source 136 may include any suitable type of ophthalmic laser light source for producing a photocoagulation laser light capable of treating retinal tissue (e.g., for performing retinopexy). For example, laser light source 136 may be configured to produce a laser light having a wavelength between about 440 nm (nanometers) and about 830 nm, such as a blue-green laser light source (e.g., 488 nm), a green laser light source (e.g., 514 nm), a high power green diode laser light source, or a red laser light source (e.g., 647 nm). In certain embodiments, laser light source 136 is an Nd:YAG laser light source (e.g., 532 nm) or a frequency-doubled CW Nd:YAG laser light source (e.g., 1064 nm). In certain embodiments, laser light source 136 produces laser light 322 having a pulse rate within a range of about 1 kilohertz (kHz) and about 500 kHz, which can effectively provide heating of the retina, though other pulse rate ranges are contemplated as well. In certain embodiments, laser light source 136 produces a continuous-wave laser light 322. For example, laser light source 136 may produce a continuous-wave laser light 322 at low power.
As shown in
In the arrangement of
In certain embodiments, optical nanofiber 410 and tapered optical fiber 420, and/or tapered optical fiber 420 and delivery fiber 430 are butt-joined at junctions 440, 442 via fusion splicing or mechanical splicing. For example, in certain embodiments, optical nanofiber 410 and tapered optical fiber 420, and/or tapered optical fiber 420 and delivery fiber 430, are mechanically spliced using an epoxy or mechanical clamping mechanism at junctions 440, 442. In further embodiments, a connector, such as a straight mating sleeve or a tapered/biconical mating sleeve, is utilized to butt-join optical nanofiber 410 and tapered optical fiber 420 at junction 440, and/or tapered optical fiber 420 and delivery fiber 430 at junction 442.
In certain embodiments, optical nanofiber 410 has a numerical aperture (NA) of about 0.66, a critical angle of about 41.3°, and a launch cone angle of 82.6°. In certain other embodiments, optical nanofiber 410 has a numerical aperture (NA) of about 0.86, a critical angle of about 59.32°, and a launch cone angle of 118.6°. To optimize coupling efficiency between optical nanofiber 410 and tapered optical fiber 420, and/or tapered optical fiber 420 and delivery fiber 430, which may otherwise be negatively affected as a result of variations in core diameters, NA, refractive-index profiles, etc., tapered optical fiber 420 can be selected based on the optical characteristics of optical nanofiber 410, and delivery fiber 430 can be selected based on the optical characteristics of tapered optical fiber 420. For example, based on the characteristics of optical nanofiber 410 described above (e.g., NA, critical angle, launch cone angle, etc.), a selected delivery fiber 430 may have a lower NA but larger diameter.
In certain embodiments, tapered optical fiber 420 and/or delivery fiber 430 may be selected based on the following formula:
A*Ω (proximal end of smaller fiber)=A*Ω (distal end of larger fiber),
wherein “A” is a cross-sectional area of the corresponding fiber end, and “Ω” is the solid angle of the corresponding fiber end's light cone. Thus, in order to optimize coupling efficiency between, e.g., optical nanofiber 410 and tapered optical fiber 420, the A*Ω product of optical nanofiber 410 may be matched to the A*Ω product of distal end 422 of tapered optical fiber 420. In certain embodiments, selecting tapered optical fiber 420 and subsequently, delivery fiber 430, based on optical characteristics of optical nanofiber 410 may provide the additional benefit of moving any coupling losses away from cannula 110 and/or handle 120, which may otherwise result in increased and undesired heat formation therein.
As shown, in addition to articulating distal tip 516, cannula 510 includes proximal portion 514, which extends axially from distal end 124 of handle 120 and may be directly or indirectly coupled to handle 120. Proximal portion 514 may generally have outer diameter D1 less than about 20 gauge, such as outer diameter D1 (shown in
Distal tip 516 may articulate in a selected direction in a controllable manner by applying tension to a control mechanism secured within cannula 510. In certain embodiments, the control mechanism includes a pull-wire or similar device extending through distal tip 516 and proximal portion 514, which may be controlled by applying tension thereto via toggle 528, such as a button, pinion, sliding pin, lever, etc., on handle 120. In certain embodiments, distal tip 516 may be articulated between straight position 560, shown in
Similar to curved portion 116 of cannula 110, distal tip 516 includes one or more aspiration ports 502 (shown in
In addition to providing aspiration, surgical instrument 500 is also configured to propagate and deliver both illumination light and laser light to the eye, e.g., eye 200, via one or more optical fibers disposed within cannula 510. Accordingly, surgical instrument 500 may have the same or substantially similar arrangements of one or more optical fibers therein, as described with reference to surgical instruments 100 and 400 and, therefore, the corresponding details are omitted for brevity. For example, surgical instrument 500 may include two optical fibers disposed therein, wherein each optical fiber is configured to propagate either illumination light or laser light, or surgical instrument 500 may include a single optical fiber, wherein the single optical fiber is configured to propagate both illumination light and laser light. To enable propagation of illumination light and/or laser light from distal tip 516, distal tip 516 may include protective window 550 at distal end 512 thereof, which provides an optically clear or transparent barrier through which laser light and/or illumination light may be transmitted during a surgical procedure. Similar to window 350, window 550 may comprise an optically clear or transparent material, such as sapphire, fused silica, or other glass or ceramics materials with high transition temperatures. In certain aspects, the transparent material may have optical power and, in certain other aspects, the transparent material may not have optical power. Accordingly, window 550 may itself be a lens, such as a spherical lens having concave or convex surfaces, or a nonspherical lens.
As described above, embodiments of the present disclosure provide a curved or articulating probe configured to provide illumination, fluid aspiration, and endophotocoagulation. Accordingly, the probe enables aspiration of subretinal fluid that re-accumulates during endophotocoagulation and after initial drainage due to posterior migration, without the need to exchange surgical instruments multiple times or insert an additional instrument into the intraocular space. Furthermore, the combined functionalities of the probe enable a surgeon to simultaneously perform scleral depression with the surgeon's other hand while aspirating fluid and/or performing retinal endophotocoagulation. As a result, utilization of the aforementioned probe enables improved procedural efficiency and reduced risk of injury to the patient's eye.
Embodiment 1: An instrument for removing subretinal fluid from an eye, comprising: a handle; an articulating cannula coupled to the handle, the articulating cannula configurable between a straight configuration and a curved configuration, the articulating cannula comprising: a lumen extending through the cannula; and at least one port adjacent to a distal end of the cannula, the port for aspirating subretinal fluid from the eye into the lumen; a first optical fiber extending through the articulating cannula, the first optical fiber for propagating an illumination light through the distal end of the cannula; and a second optical fiber extending through the articulating cannula, the second optical fiber for propagating a laser light through the distal end of the cannula.
Embodiment 2: The instrument of Embodiment 1 described above, wherein the cannula is formed from a material comprising a superelastic alloy.
Embodiment 3: The instrument of Embodiment 2 described above, wherein the superelastic alloy is nitinol.
Embodiment 4: The instrument of Embodiment 1 described above, wherein a proximal end of the handle comprises a Luer Lok-type connector to connect an extrusion tubing for aspirating the subretinal fluid.
Embodiment 5: The instrument of Embodiment 4 described above, wherein the lumen is in fluid communication with a vacuum source via the extrusion tubing.
Embodiment 6: The instrument of Embodiment 1 described above, wherein the first optical fiber and the second optical fiber are nanofibers have a diameter of about 30 microns or less.
Embodiment 7: The instrument of Embodiment 6 described above, wherein the first optical fiber is joined to a third optical fiber disposed within the handle, the third optical fiber having a tapered diameter from a proximal end thereof to a distal end thereof.
Embodiment 8: The instrument of Embodiment 7 described above, wherein the third optical fiber is joined to a fourth optical fiber at least partially disposed within the handle.
Embodiment 9: The instrument of Embodiment 6 described above, wherein the first optical fiber comprises a microlens at a distal end thereof to produce a divergent beam of illumination light.
Embodiment 10: The instrument of Embodiment 1 described above, wherein the first optical fiber is optically coupled to a light-emitting diode (LED) illumination source.
Embodiment 11: The instrument of Embodiment 1 described above, wherein the first optical fiber is optically coupled to a superluminescent diode (LED) illumination source.
Embodiment 12: The instrument of Embodiment 1 described above, wherein the second optical fiber is optically coupled to a narrowband or broadband laser source.
Embodiment 13: The instrument of Embodiment 12 described above, wherein the laser source is a supercontinuum laser source.
Embodiment 14: The instrument of Embodiment 1 described above, further comprising an optically clear or transparent window disposed within the distal end of the cannula, the window facilitating the propagation of illumination light and laser light through the distal end of the cannula.
Embodiment 15: The instrument of Embodiment 1 described above, wherein the first optical fiber and the second optical fiber are coupled to an interior sidewall of the lumen opposite the at least one port.
The above-disclosed subject matter is to be considered illustrative, and not restrictive, and the appended claims are intended to cover all such modifications, enhancements, and other embodiments which fall within the true spirit and scope of the present disclosure. Thus, to the maximum extent allowed by law, the scope of the present disclosure is to be determined by the broadest permissible interpretation of the following claims and their equivalents, and shall not be restricted or limited by the foregoing detailed description.
This application claims the benefit of priority of U.S. Provisional Patent Application Ser. No. 63/230,138 titled “VITREORETINAL INSTRUMENTS FOR ILLUMINATION, FLUID ASPIRATION, AND PHOTOCOAGULATION,” filed on Aug. 6, 2021, whose inventor is Steven T. Charles, which is hereby incorporated by reference in its entirety as though fully and completely set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
5318560 | Blount et al. | Jun 1994 | A |
5732170 | Okude et al. | Mar 1998 | A |
7141048 | Charles | Nov 2006 | B1 |
7285107 | Charles | Oct 2007 | B1 |
7470269 | Auld | Dec 2008 | B2 |
7731710 | Smith | Jun 2010 | B2 |
8297854 | Bickham et al. | Oct 2012 | B2 |
8398240 | Smith | Mar 2013 | B2 |
8485972 | Papac et al. | Jul 2013 | B2 |
8900139 | Yadlowsky | Dec 2014 | B2 |
9031371 | Yonezawa et al. | May 2015 | B2 |
9066678 | Auld | Jun 2015 | B2 |
9364982 | Schaller | Jun 2016 | B2 |
9730834 | Charles | Aug 2017 | B2 |
9795505 | Yu et al. | Oct 2017 | B2 |
10016248 | Mirsepassi | Jul 2018 | B2 |
10039669 | Heeren | Aug 2018 | B2 |
10085883 | Auld | Oct 2018 | B2 |
10238543 | Farley | Mar 2019 | B2 |
10295718 | Mirsepassi | May 2019 | B2 |
10307290 | Kern | Jun 2019 | B2 |
10376414 | Hallen | Aug 2019 | B2 |
10413446 | Bouch et al. | Sep 2019 | B2 |
10869735 | Diao et al. | Dec 2020 | B2 |
10888219 | Smith et al. | Jan 2021 | B2 |
11033427 | Charles et al. | Jun 2021 | B2 |
11160686 | Cook et al. | Nov 2021 | B2 |
11471242 | Diao | Oct 2022 | B1 |
11517392 | Mirsepassi et al. | Dec 2022 | B2 |
20060184162 | Smith | Aug 2006 | A1 |
20080177257 | Smith et al. | Jul 2008 | A1 |
20090093800 | Auld | Apr 2009 | A1 |
20110125139 | Auld | May 2011 | A1 |
20170172792 | Mirsepassi | Jun 2017 | A1 |
20180042768 | Charles | Feb 2018 | A1 |
20180078410 | Gavanescu | Mar 2018 | A1 |
20180296391 | Charles | Oct 2018 | A1 |
20180338859 | Mirsepassi | Nov 2018 | A1 |
20190046352 | Mordaunt et al. | Feb 2019 | A1 |
20190201238 | Bacher et al. | Jul 2019 | A1 |
20190282322 | Mirsepassi | Sep 2019 | A1 |
20190343681 | Heriot | Nov 2019 | A1 |
20210290438 | Hallen | Sep 2021 | A1 |
Number | Date | Country |
---|---|---|
2215995 | Aug 2010 | EP |
Entry |
---|
Alcon Vitreoretinal Product Catalog, Copyright 2008, pp. 27-29. |
Number | Date | Country | |
---|---|---|---|
20230040005 A1 | Feb 2023 | US |
Number | Date | Country | |
---|---|---|---|
63230138 | Aug 2021 | US |